醫療團隊
專業的醫護人員，提供最佳的醫療服務
醫師介紹
葉俊男醫師
胰臟外科、胃腸外科、甲狀腺手術、腹膜透析導管植入及追蹤
- 國語,英語,閩南語
- 教授
醫師網路掛號
直接點選進入醫師網路掛號畫面
醫師資歷
-
現職
- 林口長庚紀念醫院 一般外科系 系主任
- 台灣分子醫學會 理事長
- 台灣消化系外科醫學會 理事
-
學歷
- 美國約翰霍普金斯大學
- 台北醫學院醫學系
-
經歷
- 林口長庚紀念醫院 一般外科系一般外科 科主任
- 桃園長庚紀念醫院 一般外科 科主任
- 台灣胰臟醫學會秘書長
-
學會與認證
- 中華民國癌症醫學會
- 台灣消化外科醫學會
- 台灣內視鏡外科醫學會
- 台灣內分泌外科醫學會
- 台灣胰臟醫學會
- 世界肝膽胰外科醫學會
- 世界消化道外科醫學
-
論文及期刊發表
- PLK1 and its substrate MISP facilitate intrahepatic cholangiocarcinoma progression by promoting lymphatic invasion and impairing E-cadherin adherens junctions.
Cancer Gene Ther. 2023 Dec 6. doi: 10.1038/s41417-023-00705-z.
Yi-Ru Pan, Joseph Chieh-Yu Lai, Wen-Kuan Huang, Pei-Hua Peng, Shih-Ming Jung, Sheng-Hsuan Lin, Chiao-Ping Chen, Chiao-En Wu, Tsai-Hsien Hung, Alice L. Yu, Kou-Juey Wu*, Chun-Nan Yeh* - Zinc supplementation decreased incidence of grade ≧ 2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial.
EJC 2023 Nov 10:113286. doi: 10.1016/j.ejca.2023.113286.
Wen-Kuan Huang, Hung-Chih Hsu, Tsai-Sheng Yang, Chun-Wei Lu, Yi-Ru Pan, Chiao-En Wu, Wen-Hung Chung, Shuen-Iu Hung, Chun-Nan Yeh* - Zinc supplementation decreased incidence of grade ≧ 2 hand-foot skin reaction induced by regorafenib: A phase II randomizedclinical trial.
J AM ACAD DERMATOL 2023 . https://doi.org/10.1016/j.jaad.2023.06.055
Wen-Kuan Huang, Hung-Chih Hsu, Tsai-Sheng Yang, Chun-Wei Lu, Yi-Ru Pan, Chiao-En Wu, Wen-Hung Chung, Shuen-Iu Hung, Chun-Nan Yeh* - Wee1 inhibition by MK1775 potentiates gemcitabine through accumulated replication stress leading to apoptosis in biliary tract cancer.
Biomed Pharmacother. 2023 Aug 31;166:115389. doi: 10.1016/j.biopha.2023.115389. PMID: 37659202
Chen CP, Yeh CN(共同第一), Pan YR, Huang WK, Hsiao YT, Lo CH, Wu CE - Hepatitis C accelerates extrahepatic cholangiocarcinoma risk: a joint study of hospital-based cases and nationwide population-based cohorts in a viral hepatitis-endemic area.
Am J Cancer Res 2023;13(7):3080-3090.
Shu-Wei Huang, Jur-Shan Cheng, Wei-Ting Chen, Ting-Shu Wu, Hsin-Ping Ku, Chun-Nan Yeh*,Rong-Nan Chien, Ming-Ling Chang - Mucin 4 Confers Gemcitabine Resistance and an Unfavorable Prognosis in Patients with Cholangiocarcinoma via AKT Activation.
Int. J. Biol. Sci. 2023; 19(9): 2772-2786.
Yi-Ru Pan, Chiao-En Wu(共同第一), Shih-Ming Jung, Shih-Chiang Huang, Sheng-Hsuan Lin, Wen-Chi Chou, Yu-Chan Chang, Ming-Huang Chen, Tsai-Hsien Hung, Alice L. Yu, Wen-Kuan Huang*,Chun-Nan Yeh* - Intraductal papillary neoplasm of the bile duct presenting with hepatogastric fistula: a case report and literature review.
Frontiers in Oncology. 2023 Mar 19. DOI 10.3389/fonc.2023.1193918
Wen-Hui Chan, Chien-Ming Chen, Shang-Yu Wang, Ren-Chin Wu, Tse-Ching Chen, Hao-Kang Lee, Cheng-Hui Lin, Chun-Nan Yeh* - Risk factors of recurrent secondary hyperparathyroidism after adequate primary surgical treatment.
Front Endocrinol (Lausanne) 2023 Feb 3;14:1063837. doi: 10.3389/fendo.2023.1063837.
Yu-Chi Kuo, Shang-Yu Wang(共同第一), Yu-Liang Hung, Chih-Chieh Hsu, Hao-Wei Kou, Ming-Yang Chen, Chun-Yi Tsai, Chih-Hsiang Chang, Yu-Chao Wang, Jun-Te Hsu, Ta-Sen Yeh, Wei-Chen Lee, Chun-Nan Yeh* - Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report.
JCO Precis Oncol. 2023;7:e2200528. DOI https://doi.org/10.1200/PO.22.00528
Wen-Kuan Huang, Shih-Chiang Huang, Chien-Ming Chen, Po-Hung Lin, Chiao-En Wu, Cheng-Keng Chuang, Chun-Nan Yeh* - A Potential Association of Zinc Deficiency and Tyrosine Kinase Inhibitor-Induced Hand-Foot Skin Reaction.
Biol Trace Elem Res. 2023 Mar 9. doi: 10.1007/s12011-023-03618-y.
Chun-Nan Yeh, Wen-Kuan Huang, Chun-Wei Lu, Chiao-Ping Chen, Sheng-Hsuan Lin, Yi-Ru Pan, Chiao-En Wu*. - Letter to the editors on 'Clinical efficacy of lenvatinib for the treatment of radioiodine-refractory thyroid carcinoma: A systematic review and meta-analysis of clinical trials
Clin Endocrinol (Oxf). 2023 Jan;98(1):133. doi: 10.1111/cen.14565. Epub 2021 Jul 27.
Li YR, Wang SY, Yeh CN*.
- PLK1 and its substrate MISP facilitate intrahepatic cholangiocarcinoma progression by promoting lymphatic invasion and impairing E-cadherin adherens junctions.